NDC 72301-595

Jeuveau

Prabotulinum Toxin Type A

Jeuveau is a Intramuscular Powder in the Human Prescription Drug category. It is labeled and distributed by Evolus, Inc.. The primary component is Botulinum Toxin Type A.

Product ID72301-595_2ca5b2df-12ce-48f2-b446-f9a69f923539
NDC72301-595
Product TypeHuman Prescription Drug
Proprietary NameJeuveau
Generic NamePrabotulinum Toxin Type A
Dosage FormPowder
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2019-02-13
Marketing CategoryBLA / BLA
Application NumberBLA761085
Labeler NameEvolus, Inc.
Substance NameBOTULINUM TOXIN TYPE A
Active Ingredient Strength100 [USP'U]/1
Pharm ClassesAcetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72301-595-10

1 VIAL in 1 CARTON (72301-595-10) > 1 POWDER in 1 VIAL
Marketing Start Date2019-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72301-595-10 [72301059510]

Jeuveau POWDER
Marketing CategoryBLA
Application NumberBLA761085
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-02-13

Drug Details

Active Ingredients

IngredientStrength
BOTULINUM TOXIN TYPE A100 [USP'U]/1

OpenFDA Data

SPL SET ID:17a914c1-e54b-4b50-965d-b0fd9111bba4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2117871
  • 2117876
  • Pharmacological Class

    • Acetylcholine Release Inhibitor [EPC]
    • Acetylcholine Release Inhibitors [MoA]

    Trademark Results [Jeuveau]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    JEUVEAU
    JEUVEAU
    87464767 not registered Live/Pending
    Evolus, Inc.
    2017-05-25

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.